DA Davidson reduces its price target from $7 to $6 on Buy-rated AXT AXTI as Gallium pricing is impacting margins on in-line revenues.
DA Davidson notes, "AXTI reported Q1 EPS of $0.05 on revenues of $23.5 million (+10.7% from Q4:CY11 and -4.4% from Q1:CY11) versus consensus expectations of $0.09 on $22.6 million and our $0.09 on $23 million estimate. EPS fell shy of both consensus and our estimates due to low Gallium raw material prices, which caused gross margins to come in at 34.9% versus our and consensus estimates of 37.0% and 37.6%, respectively."
AXTI closed at $5.05 on Wednesday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in